Fangzhou Inc. Amplifies Collaborations with Tencent and Baidu, Launching Revolutionary AI Healthcare Solution

Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu through Innovative AI Solutions

On November 22, 2024, Fangzhou Inc., a prominent player in Internet healthcare solutions, hosted a significant summit titled Data and AI Decoding Digital Engagement in Chengdu, China. This event convened major stakeholders from the healthcare and technology sectors, including representatives from tech giants Tencent and Baidu, as well as executives from over 30 leading pharmaceutical firms. During the summit, discussions revolved around collaborative strategies focusing on user growth and business performance enhancements through advanced digital marketing initiatives.

The summit not only marked a pivotal moment for Fangzhou but also solidified its strategic alliances with Tencent Healthcare and Baidu Health. By merging Fangzhou’s expertise in chronic disease management with the technological prowess of Tencent and Baidu in mobile ecosystems and AI research, the partnership aims to create a seamless user journey from health content discovery to ongoing disease management. This innovative approach is set to optimize digital marketing effectiveness and user engagement throughout the patient lifecycle.

Dr. Xie Fangmin, the visionary founder and CEO of Fangzhou, emphasized the transformative nature of these collaborations, stating, "This partnership is a landmark move in our quest to revolutionize Internet healthcare. By joining forces with key industry players, we are not just broadening our reach; we are redefining the healthcare ecosystem. Our ambition is to develop a user-centric platform that provides extensive and high-quality health services to millions of users. This venture is a commitment to shaping the future of healthcare in China."

Unveiling the AI Agent Solution

A significant highlight of the summit was the launch of Fangzhou's groundbreaking healthcare-oriented AI Agent Solution. This suite of tools is designed to enhance access to vital healthcare information and analysis for individuals and healthcare professionals alike. Consumers can access a mini program offered by Fangzhou, which simplifies the process of locating health and diagnostic information and provides tailored interpretations for over fifty types of medical reports.

For healthcare professionals, Fangzhou introduced its AI Academic Interaction Assistant, which significantly boosts research efficiency in scientific content. Featuring advanced capabilities like voice input, bilingual search support (Chinese and English), and automated literature summaries, this innovative tool can reduce search time by as much as 80%. This commitment to harnessing technology is expected to not only pave new pathways for health management but also aligns with Fangzhou’s mission of empowering both users and healthcare professionals with state-of-the-art solutions.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) stands at the forefront of online chronic disease management in China, boasting an impressive 45.6 million registered users and 217,000 registered doctors as of June 30, 2024. The company specializes in providing customized medical care and precision medicine to meet the diverse needs of the chronic disease patient population. To learn more, please visit Fangzhou's investor site.

About Tencent and Baidu

Both Tencent and Baidu are recognized as key players in the digital technology sphere, committed to enhancing the lives of internet users and bolstering operational efficacy for partners across various sectors, including healthcare, insurance, and pharmaceuticals.

Final Thoughts

As Fangzhou Inc. embarks on this revolutionary partnership and product launch, the potential for transforming the online healthcare landscape in China appears promising. With a focus on innovation, collaboration, and user empowerment, Fangzhou is set to make strides in addressing the complexities of chronic disease management and enhancing the overall patient experience in the digital age.

For further information or inquiries regarding this partnership and its implications, media contacts are encouraged to reach out to Xingwei Zhao, Associate Director of Public Relations.